Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul Varki files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Ryan Sullivan - $3.34M of AVTX open-market activity in the last 12 months
- Mittie Doyle - $2.96M of AVTX open-market activity in the last 12 months
- Jonathan Goldman - $163K of AVTX open-market activity in the last 12 months
- Mitchell Chan - $72K of AVTX open-market activity in the last 12 months
- Jennifer Riley - $52K of AVTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul Varki?
Paul Varki is a corporate insider, tracked as Chief Legal Officer of Avalo Therapeutics, Inc. (AVTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paul Varki submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Paul Varki been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.51M) across all tracked filings.
Where can I see all of Paul Varki's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Paul Varki and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
